SWITCHING
THE VIEW

To date, the collective research on transcription factors has been elusive to drug discovery. However, Flare Therapeutics has now reached a moment of light – with the prospect of forever changing the trajectory of how we treat disease.

  Science

 

Flare Therapeutics’ pipeline is Initially focused on precision oncology.

Our small molecules are designed to regain transcriptional control that is hijacked by cancer.

  Pipeline

 
 

ENLIGHTEN
YOUR PATH

Intensity, empathy, determination, and brilliance. The Flare Therapeutics team is a living, growing, thriving organization of talented people and bright minds. We are always looking for new sparks to flame our collective fire. Learn more about our culture and join us!

  Join Us

Press Releases

January 9, 2026

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer


In the News

January 1, 2026

Cancer Discovery

First-of-Its-Kind PPARG Inhibitor Shows Compelling Activity
 

This links to an external website.

Continue